Top 5 Warren Buffett Stocks To Own For 2018

Following billionaire investor Warren Buffett into stocks he owns has often been a profitable strategy over the past few decades. But reversing the orderbuying a stock before Buffett buys itcan potentially be even more rewarding.

Quiz: How Well Do You Really Know Warren Buffett?

With that in mind, we went prospecting for companies that Berkshire Hathaway (BRK-B, $137), Buffetts holding company, has been buying recently, and four stocks that Buffett doesnt hold but we think he ought to buy. We looked for the things he favors: com颅panies that are leaders in their industries, that have a strong commitment to sharing profit with investors, and whose stocks sell for relatively low prices compared with earnings and underlying asset value.

A few caveats: First, even Buffett makes mistakes. Second, many of Berkshires picks are now made by Buffetts two investing deputies, Todd Combs and Ted Weschler, not Buffett himself. And third, anyone guessing which stocks might be attractive to Berkshire is doing just thatguessing.

Top 5 Warren Buffett Stocks To Own For 2018: BorgWarner Inc.(BWA)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Yesterday, I dubbed the selloff in auto stocks “car-pocalypse now,” as shares of everything car related tumbled following disappointing auto sales. Shares of General Motors (GM) and Ford Motor (F)? Check. Auto-part makers like BorgWarner (BWA)? Check. Used-car sellers like AutoNation (AN) and CarMax (KMX)? Check. Auto-part retailers like O’Reilly Automotive (ORLY) and AutoZone (AZO)? Oh yeah. So is it time to panic?

  • [By Ben Levisohn]

    Yesterday, Morgan Stanleys Adam Jonas cut Delphi Automotive (DLPH) to Underweight from Overweight citing the threat posed by electric cars (and not just Tesla Motors (TSLA)). Today, Bairds David Leiker and team offer a fuller defense of Delphi Automotive, as well as Borg Warner (BWA) and Lear (LEA):

Top 5 Warren Buffett Stocks To Own For 2018: Hercules Offshore Inc.(HERO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Hercules Offshore, Inc. (NASDAQ: HERO) shares dropped 46 percent to $1.05 as the company reported that it has entered into a restructuring support agreement with lenders.

  • [By Monica Gerson]

    Hercules Offshore, Inc. (NASDAQ: HERO) is estimated to post a quarterly loss at $1.79 per share on revenue of $68.65 million.

    You On Demand Holdings, Inc. (NASDAQ: YOD) is expected to report its quarterly earnings.

Top 5 Warren Buffett Stocks To Own For 2018: American International Group Inc.(AIG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    BMO’s Charles Sebaski explains why he upgraded American International Group (AIG) to Outperform from market Perform:

    Agence France-Presse/Getty Images

    AIG has been trading at discount to its tangible book given its mid-single digit return profile; however, we expect AIGs valuation to keep increasing with its improving return profile. We are now forecasting AIG to generate a 9.9% operating return on tangible common equity (ROtE) in 2018, which would be a 450 bp improvement from 2016. A double-digit return profile warrants the 1x multiple that we are applying to its tangible book value per share. While we expect AIGs return profile to benefit from lower taxes, we also expect the companys life and retirement business to improve from the rising interest rates as those spread businesses are more interest rate sensitive than the P&C business. That said, we expect continued improvement on both the loss and expense sides of the P&C as contributing factors to the ROtE improve.

    BMO also upgraded Arch Capital Group (ACGL), Brown & Brown (BRO), and Travelers (TRV).

    Shares of American International Group have declined 0.4% to $65.60 at 3:36 p.m. today, whileArch Capital Group has gained 2% to $87.90,Brown & Brown has advanced 0.5% to $44.65, andTravelers has risen 1.3% to $120.79.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Heading into its earnings following the close of trading yesterday, shares of American International Group (AIG) had gained 34% from its low on Jun. 28 to Feb. 14. Then the bottom fell out.

  • [By Dan Caplinger]

    Wednesday was yet another record-setting day for the stock market, as the Dow climbed triple digits and the S&P 500 and Nasdaq Composite followed the venerable average to unprecedented heights. Economic data showing rising inflation made it more likely that the Federal Reserve will look to boost interest rates at its next Federal Open Market Committee meeting next month, and the ripples throughout the bond market sent many investors to consider stocks instead. Yet despite the substantial rally, some stocks missed out on the move higher, and American International Group (NYSE:AIG), Teck Resources (NYSE:TECK), and Movado Group (NYSE:MOV) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Top 5 Warren Buffett Stocks To Own For 2018: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Benzinga News Desk]

    On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link

    ECONOMIC DATA
    March 2017 US Challenger layoffs report 43,310 vs 36,975
    Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate.
    San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
    Data on money supply for the recent week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell
    JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform
    PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight
    Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold
    Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

Top 5 Warren Buffett Stocks To Own For 2018: General Motors Company(GM)

Advisors’ Opinion:

  • [By ]

    Automakers such as General Motors (NYSE: GM) aren’t enthusiastic supporters either. Aluminum and steel account for roughly 65% of the weight of an average vehicle. Goldman Sachs calculates that tariff-related price increases for these key building blocks could wipe out up to $1 billion from the company’s annual profits.

  • [By WWW.KIPLINGER.COM]

    The market is rightly worried about General Motors Co. (GM) hitting the peak of the latest car-buying cycle, but its overdoing its concerns. It feels like GM stock has been discounted for a worst-case scenario, if not more.

  • [By Douglas A. McIntyre]

    General Motors Co. (NYSE: GM) wants to test cars without a steering wheel. According to CNBC:

    Would you get in a self-driving car that has no steering wheel and no pedals? General Motors thinks so, and wants to test its newest autonomous-driving vehicle on public roads and highways starting in 2019.

  • [By Kumar Abhishek]

    Shares of California-basedelectric car manufacturer Tesla Inc (NASDAQ:TSLA)had a strong bullish rally in the past six months, gaining more than 50% in this period and surpassing General Motors (NYSE:GM) and Ford (NYSE:F) as the most valuable car company in the United States. Apart from the general market rally, the close proximity of CEO Elon Musk with Trump administration, the positive news about its Gigafactory, the recent beat on delivery numbers and to an extent developments on the Model3 front have contributed to the bullish rally. However, the rally has also brought back the focus on Tesla stock valuation.

  • [By Dustin Blitchok]

    General Motors Company (NYSE: GM), Fiat Chrysler Automobiles NV (NYSE: FCAU) and Ford Motor Company (NYSE: F) “will go broke again” if NAFTA is dismantled, Fox told Benzinga. “They will not be able to survive. They will not be competitive.”